Generic heart drug shows promise in small study
NCT ID NCT07396506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a generic version of dronedarone hydrochloride tablets works the same as the brand-name drug MULTAQ in healthy adults. Fifty-one healthy male volunteers took a single dose of either the generic or brand drug under fasting conditions. The results showed the generic was bioequivalent, meaning it releases the same amount of drug into the bloodstream.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Dronedarone hydrochloride tablets (400 mg)
What this could lead to
If successful, this could provide a more affordable generic version of dronedarone for managing atrial fibrillation.
What could go wrong
This was a small, early-stage bioequivalence study in healthy volunteers, not patients. It does not test safety or effectiveness for treating atrial fibrillation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jiangxi Cancer Hospital ＆ Institute (The Second Affiliated Hospital of Nanchang Medical College)
Nanchang, Jiangxi, 330029, China